Preclinical Results For Pluristem Therapeutics's PLX-PAD Cells In Tendon Injury Presented At American Academy of Orthopaedic Surgeons' Annual Meeting

Published: Mar 12, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HAIFA, Israel, March 12, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced that Dr. Scott Rodeo of New York's Hospital for Special Surgery (HSS) presented his research findings in a scientific poster titled, "Use of Human Placental-Derived Adherent Stromal Cells Improves Tendon Healing in a Preclinical Model of Tendon Injury," at the American Academy of Orthopedic Surgeons' (AAOS) Annual Meeting, on March 11-15 in New Orleans. - See more at: http://www.globenewswire.com/news-release/2014/03/12/617606/10072308/en/Preclinical-Results-for-Pluristem-s-PLX-PAD-Cells-in-Tendon-Injury-Presented-at-American-Academy-of-Orthopedic-Surgeons-Annual-Meeting.html#sthash.AJgzyRLk.dpuf

Help employers find you! Check out all the jobs and post your resume.

Back to news